XML 28 R1.htm IDEA: XBRL DOCUMENT v3.25.4
Cover - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Feb. 16, 2026
Jun. 28, 2024
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-40097    
Entity Registrant Name GINKGO BIOWORKS HOLDINGS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 87-2652913    
Entity Address, Address Line One 27 Drydock Avenue    
Entity Address, Address Line Two 8th Floor    
Entity Address, City or Town Boston    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 02210    
City Area Code 877    
Local Phone Number 422-5362    
Title of 12(b) Security Class A common stock, par value $0.0001 per share    
Trading Symbol DNA    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 553
Documents Incorporated by Reference
The information required by Part III of this report is incorporated by reference from the registrant’s definitive proxy statement relating to its annual meeting of stockholders to be held in 2026, which definitive proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.
    
Amendment Flag false    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001830214    
Common Class A      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   49,941,878  
Common Class B      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   8,982,474  
Nonvoting Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   3,000,000